All Eyes On Sanofi’s MS Efforts As Aubagio Plummets Upon Generic Entries

Dupixent Still On The Rise

 
• By Ayisha Sharma
  
doctor holding mri brain scan images
Frexalimab reduced new gadolinium-enhancing T1 brain lesions by 89% • Source: Shutterstock

More from Earnings

More from Business